benzinga.com · Nov 6, 2025
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal
Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92.
NYSE · BDXA
Becton, Dickinson and Company
Healthcare · Medical - Instruments & Supplies
$59.24
Down-$1.36 (-2.24%)
Updated Aug 14, 2026, 11:27 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 55.91B
- P/E ratio
- 34.23
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 6.15M
- Avg. volume
- 0
Price performance
BDXA price history
1M range · 0 trading sessions · Daily adjusted prices
BDXA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest BDXA news
The latest Smart Investors Daily articles mentioning BDXA.
Stock researchCompany · Overview
BDXA research
Overview
Company profile and research snapshot.
Company profile
A detailed company description is not available yet.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
